Pharmaceutical sciences

Advanced Container Technologies Offers Customized Packaging for Companies Looking to Launch or Build Brands in the Cannabis and CBD Sectors

Retrieved on: 
Wednesday, July 14, 2021
Medicinal plants, Health sciences, Medicine, Pharmaceutical sciences, Cannabis, Entheogens, Euphoriants, Herbs, Soma, Medical cannabis, CBD

CORONA, Calif., July 14, 2021 (GLOBE NEWSWIRE) -- Advanced Container Technologies, Inc (Ticker: ACTX), announced its customizable packaging solutions provide the foundation that allows cannabis and CBD companies to create beautiful brands at an affordable price.

Key Points: 
  • CORONA, Calif., July 14, 2021 (GLOBE NEWSWIRE) -- Advanced Container Technologies, Inc (Ticker: ACTX), announced its customizable packaging solutions provide the foundation that allows cannabis and CBD companies to create beautiful brands at an affordable price.
  • According to an article in MJBizDaily , sales of cannabis pre-rolls surged nearly 50% last year in key recreational markets.
  • Doug Heldoorn, CEO of Advanced Container Technologies, said the company is now providing customized pre-roll packaging to cannabis and CBD businesses throughout the nation.
  • For more information on how to grow your cannabis or CBD business with quality customized packaging, contact Advanced Container Technologies, at: (951) 381-2555 or visit: www.advancedcontainertechnologies.com .

CBD of Denver Positioning to Meet Rapid Increase in Demand for Cannabis from Upcoming Launch of Swiss Pilot Projects for Controlled Distribution

Retrieved on: 
Tuesday, July 13, 2021
Herbs, Medicinal plants, Health sciences, Medicine, Pharmaceutical sciences, Biofuels, Hemp, Medical cannabis, Cannabis

"The Federal Office of Public Health expects several tons of product will be needed to meet initial demand.

Key Points: 
  • "The Federal Office of Public Health expects several tons of product will be needed to meet initial demand.
  • This could be another revenue and profit boost for our Swiss business while fortifying our overall foundation across Europe," commented Marcel Gamma, CEO of CBD of Denver.
  • CBD of Denver, Inc., Rockflowr GmbH and Swiss Industry Ventures AG are now also on LinkedIn.
  • CBD of Denver, Inc. (OTC Pink: CBDD) a full-line CBD and Hemp oil company ("CBDD") and a producer and distributor of Cannabis and CBD products in Switzerland and Europe.

Pharvaris Presents Clinical Data on Oral PHA121 Supporting the Prophylactic Treatment of Hereditary Angioedema at the EAACI Annual Congress 2021

Retrieved on: 
Friday, July 9, 2021
Health sciences, Pharmacology, Dosage forms, Pharmaceutical sciences, Tablet, Capsule, Formulation, Modified-release dosage, Softgel

The data also show that PHA121 was well absorbed with median times to reach peak plasma levels within 1.00 to 1.75 hours after dosing with standard meals.

Key Points: 
  • The data also show that PHA121 was well absorbed with median times to reach peak plasma levels within 1.00 to 1.75 hours after dosing with standard meals.
  • Pharvaris remains committed to providing patients with oral alternatives both for on-demand and prophylactic treatment in HAE via our softgel capsule formulation, PHVS416, and extended-release tablet formulation, PHVS719.
  • Pharvaris is developing this formulation to provide rapid exposure of attack-mitigating medicine in a convenient, small oral dosage form.
  • Pharvaris is developing this novel small molecule for on-demand and prophylactic treatment of HAE and other bradykinin-mediated diseases through formulations optimized for each setting.

OnMi Transdermal Patches Now Available on OneLavi.com

Retrieved on: 
Friday, July 9, 2021
Health sciences, Pharmacology, Pharmaceutical sciences, Routes of administration, Dosage forms, Transdermal patch, Pharmacokinetics, Transdermal, Dermal patch, Prostate Adenocarcinoma: TransCutaneous Hormones, Sugar

PALM BEACH, FL, July 09, 2021 (GLOBE NEWSWIRE) -- American consumers, who have difficulty or dislike swallowing pills, now have easy and effective transdermal patches from OnMi available at OneLavi.com .

Key Points: 
  • PALM BEACH, FL, July 09, 2021 (GLOBE NEWSWIRE) -- American consumers, who have difficulty or dislike swallowing pills, now have easy and effective transdermal patches from OnMi available at OneLavi.com .
  • We are thrilled that OneLavi.com has chosen to offer OnMi patches to its consumers, said Ryan McFarlane, COO of OnMi, a Miami-based health and wellness company.
  • OnMi patches deliver vitamins and plant extracts without sugar and potentially harmful filler ingredients.
  • OnMi also recently introduced its transdermal patches to approximately 50 buyers from large and small retail chains in the United States.

2021 Report on Pulmonary Radiation Toxicity (Toxicology) Drugs in Development - ResearchAndMarkets.com

Retrieved on: 
Thursday, July 8, 2021
Health, Pharmaceutical, Health sciences, Pharmacology, Pharmaceutical sciences, Natural sciences, Toxicology, Pharmacodynamics, Mechanism of action, Radiation therapy, Toxicity

The "Pulmonary Radiation Toxicity (Toxicology) - Drugs in Development, 2021" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Pulmonary Radiation Toxicity (Toxicology) - Drugs in Development, 2021" report has been added to ResearchAndMarkets.com's offering.
  • This report provides comprehensive information on the therapeutics under development for Pulmonary Radiation Toxicity , complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type.
  • Additionally, the report provides an overview of key players involved in therapeutic development for Pulmonary Radiation Toxicity and features dormant and discontinued projects.
  • The report reviews key players involved in the development of Pulmonary Radiation Toxicity (Toxicology) therapeutics and enlists all their major and minor projects.

Cultivators at Trade Roots have chosen Revolution Micro's LED technology for their premiere craft cannabis facility

Retrieved on: 
Wednesday, July 7, 2021
Medicinal plants, Health sciences, Herbalism, Entheogens, Euphoriants, Pharmaceutical sciences, Medicine, Cannabis law, Cannabis, Medical cannabis, Legality of cannabis, Dispensary

Carl Giannone, co-founder of Trade Roots, is striving to create an entirely new experience for cannabis enthusiasts who visit the Massachusetts dispensary.

Key Points: 
  • Carl Giannone, co-founder of Trade Roots, is striving to create an entirely new experience for cannabis enthusiasts who visit the Massachusetts dispensary.
  • In addition to a beautiful atmosphere, the company is also striving to produce eco-friendly, high quality cannabis.
  • Co-founder Jesse Pitts defined craft as "doing all the right things, even if no one will see it."
  • With an opening anticipated in the fall, the Trade Roots dispensary is ready to sell cannabis that drives innovation, and supports the environment and local community.

Silo Pharma extends agreement for experimental Rheumatoid Arthritis nanoparticle homing peptide

Retrieved on: 
Wednesday, July 7, 2021
Life sciences, Health sciences, Pharmacy, Pharmaceutical sciences, Biotechnology, Pharmaceutical industry, Biopharmaceutical, Pharma, Silos

This extended option gives Silo further evaluation period to access this unique and potentially vital therapeutic that can also act as a drug delivery platform, stated Eric Weisblum, Chairman and CEO of Silo Pharma.

Key Points: 
  • This extended option gives Silo further evaluation period to access this unique and potentially vital therapeutic that can also act as a drug delivery platform, stated Eric Weisblum, Chairman and CEO of Silo Pharma.
  • Silo Pharma is a development stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research for people suffering from indications such as depression, PTSD, Parkinsons, and other rare neurological disorders.
  • Silos mission is to identify assets to license and fund the research which we believe will be transformative to the well-being of patients and the health care industry.
  • This news release contains "forward-looking statements" within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.

Biofrontera reports preliminary revenue for the month of June 2021

Retrieved on: 
Tuesday, July 6, 2021
Health sciences, Skin care, Pharmaceutical sciences, Life sciences, Pharmaceutical industry, Pharmacology, Pharmacy, Cosmetics, Pharmaceuticals policy, Pharmaceutical industry in China, Draft:Flen Health

The Germany-based company, with over 150 employees worldwide, develops and markets innovative products for the care, protection and treatment of the skin.

Key Points: 
  • The Germany-based company, with over 150 employees worldwide, develops and markets innovative products for the care, protection and treatment of the skin.
  • Ameluz has been marketed in the EU since 2012 and in the United States since May 2016.
  • In the EU, the company also sells the dermocosmetics series Belixos, which offers specialized care for damaged or diseased skin.
  • Biofrontera is the first German founder-led pharmaceutical company to receive a centralized European and a US approval for a drug developed in-house.

Pharmaceutical Water Market Report 2020 - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018-2030 - ResearchAndMarkets.com

Retrieved on: 
Monday, July 5, 2021
Health, Pharmaceutical, Health sciences, Pharmaceutical industry, Pharmacology, Pharmacy, Pharmaceutical sciences, Market, Health care, Pharmaceutical industry in China

The "Pharmaceutical Water Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020-2030" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Pharmaceutical Water Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020-2030" report has been added to ResearchAndMarkets.com's offering.
  • The report also provides the compound annual growth rate (CAGR %) for the global pharmaceutical water market during the forecast period.
  • Furthermore, the report sheds light on changing competitive dynamics in the global pharmaceutical water market.
  • These indices serve as valuable tools for existing market players as well as for entities interested in entering the global pharmaceutical water market.

GABY Inc. Discusses Mankind Merger and Launch of Kind Republic Cannabis Brand with The Stock Day Podcast

Retrieved on: 
Thursday, July 1, 2021
Health sciences, Medicine, Pharmaceutical sciences, Antiemetics, Medical cannabis, Pharmaceuticals policy, Pharmacognosy, Legality of cannabis

"We're on track to do $40 million in revenue this year, and we are cash flow positive," said Micallef.

Key Points: 
  • "We're on track to do $40 million in revenue this year, and we are cash flow positive," said Micallef.
  • Jolly then asked about a recent release on June 17th detailing the Company's launch of their cannabis brand, Kind Republic.
  • Mankind is a well-known, and highly respected dispensary with deep roots in the California cannabis community operating in San Diego, California.
  • GABY curates and sells a diverse portfolio of products, including its own proprietary brands, Kind Republic, Sonoma Pacific and Lulu's through Mankind.